Immunic slips on pricing $45M equity offering
- Immunic (NASDAQ:IMUX) is down -20.18%
pre-market after announcing the pricing of its common stock public offering. - The underwritten public offering will comprise 4,500,000 common shares, offered at a price of $10/share. Gross proceeds are expected be ~$45M….
